1. Home
  2. CNTX vs QIPT Comparison

CNTX vs QIPT Comparison

Compare CNTX & QIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNTX
  • QIPT
  • Stock Information
  • Founded
  • CNTX 2015
  • QIPT 1993
  • Country
  • CNTX United States
  • QIPT United States
  • Employees
  • CNTX 9
  • QIPT N/A
  • Industry
  • CNTX Biotechnology: Pharmaceutical Preparations
  • QIPT
  • Sector
  • CNTX Health Care
  • QIPT
  • Exchange
  • CNTX Nasdaq
  • QIPT Nasdaq
  • Market Cap
  • CNTX 78.0M
  • QIPT 92.2M
  • IPO Year
  • CNTX 2021
  • QIPT N/A
  • Fundamental
  • Price
  • CNTX $0.78
  • QIPT $2.18
  • Analyst Decision
  • CNTX Strong Buy
  • QIPT Strong Buy
  • Analyst Count
  • CNTX 6
  • QIPT 2
  • Target Price
  • CNTX $6.50
  • QIPT $6.50
  • AVG Volume (30 Days)
  • CNTX 94.4K
  • QIPT 98.5K
  • Earning Date
  • CNTX 05-07-2025
  • QIPT 05-12-2025
  • Dividend Yield
  • CNTX N/A
  • QIPT N/A
  • EPS Growth
  • CNTX N/A
  • QIPT N/A
  • EPS
  • CNTX N/A
  • QIPT N/A
  • Revenue
  • CNTX N/A
  • QIPT $244,723,000.00
  • Revenue This Year
  • CNTX N/A
  • QIPT $3.35
  • Revenue Next Year
  • CNTX N/A
  • QIPT $5.39
  • P/E Ratio
  • CNTX N/A
  • QIPT N/A
  • Revenue Growth
  • CNTX N/A
  • QIPT 3.82
  • 52 Week Low
  • CNTX $0.55
  • QIPT $1.86
  • 52 Week High
  • CNTX $2.75
  • QIPT $4.17
  • Technical
  • Relative Strength Index (RSI)
  • CNTX 45.08
  • QIPT 51.50
  • Support Level
  • CNTX $0.74
  • QIPT $2.07
  • Resistance Level
  • CNTX $0.85
  • QIPT $2.25
  • Average True Range (ATR)
  • CNTX 0.09
  • QIPT 0.08
  • MACD
  • CNTX -0.02
  • QIPT 0.02
  • Stochastic Oscillator
  • CNTX 13.67
  • QIPT 72.55

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

About QIPT Quipt Home Medical Corp.

Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The Company operates in one business segment, which is the sale and rental of medical equipment and related devices. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.

Share on Social Networks: